Acute renal failure after intravitreal antivascular endothelial growth factor therapy.
Department of Ophthalmology, Taichung Veterans General Hospital, Taichung, Taiwan.
Yu-Fang
YF
Huang
Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Ophthalmology, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Shih-Jen
SJ
Chen
Department of Ophthalmology, Taichung Veterans General Hospital, Taichung, Taiwan; Institute of Nano-engineering and Microsystems, National Tsing Hua University, Hsinchu, Taiwan.
Min-Yen
MY
Hsu
Department of Ophthalmology, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Ophthalmology, School of Medicine, National Yang-Ming University, Taipei, Taiwan. Electronic address: m95gbk@hotmail.com.tw.
De-Kuang
DK
Hwang
D058186:Acute Kidney Injury / Q000188:drug therapy*; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000068258:Bevacizumab / Q000008:administration & dosage; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D000069579:Ranibizumab / Q000008:administration & dosage; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab